Tracey A. Rouault - Bethesda MD, US James B. Mitchell - Damascus MD, US Murali Krishna Cherukuri - Gaithersburg MD, US Manik Ghosh - North Potomac MD, US
Assignee:
Office of Technology Transfer, NIH - Bethesda MD
International Classification:
A61K 31/45 A61P 25/16 A61P 25/28
US Classification:
514315
Abstract:
A method of treating or preventing neurodegeneration in a mammal comprising administering to the mammal an effective amount of a stable nitroxide radical, such as Tempo as well as related methods.